97775859 - YORHAEVEN

Information

• Trademark
• 97775859

• Source

• Serial Number

  97775859

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  February 01, 2023
  a year ago

• Transaction Date

  January 29, 2024
  5 months ago

• Status Date

  October 29, 2023
  8 months ago

• Location Date

  October 29, 2023
  8 months ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  MARTIN, LIEF ANDREW

• Attorney Docket Number

  034845.366

  Attorney Name

  Scott D. Woldow

  Law Office Assigned Location Code

  M30

• Owners

  • CSL BEHRING AG

Case File Statements

• GS0051: Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations, namely, for the treatment of Hereditary Angioedema, HAE, respiratory diseases, acute respiratory distress syndrome, ARDS, Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; antibodies

Case File Event Statements

• 1/29/2024 - 5 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/29/2023 - 8 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/29/2023 - 8 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/29/2023 - 8 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/27/2023 - 8 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/7/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/7/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP